Access cutting-edge cystic fibrosis treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access cystic fibrosis specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cystic fibrosis treatment provided free
This is a Phase 1/2 multicenter, open-label, single dose trial of SP-101 investigational gene therapy in adults with CF who are ineligible for or intolerant to CFTR modulator therapy.
Sponsor: Spirovant Sciences, Inc.
Check if you qualify for this cystic fibrosis clinical trial in Philadelphia, PA
If you're searching for cystic fibrosis treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cystic fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.